SuperworthGuardant Health profit margin GH
Gross, operating and net profit as a share of revenue over the last twelve months, from 2018.
- Net margin, 12 months
- −38.3%
- Operating margin, 12 months
- −39.7%
- Net margin on a year earlier
- +11.6 pts
- Peer median
- 13.4%
Over the twelve months to Jun 30, 2026, Guardant Health kept −38.3% of its revenue as net profit, with an operating margin of −39.7% and a gross margin of 65.0%.
The median for 10 diagnostics and research stocks of a similar size is 13.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −42.4% | −44.5% | 64.5% |
| FY2024 | −59.0% | −60.0% | 60.8% |
| FY2023 | −85.0% | n/a | 59.7% |
| FY2022 | n/a | n/a | 65.2% |
| FY2021 | n/a | n/a | 67.1% |
| FY2020 | −85.9% | −88.9% | 67.7% |
| FY2019 | −35.3% | −38.4% | 67.0% |
| FY2018 | −93.8% | n/a | 52.3% |
| FY2017 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −38.3% | +11.6 pts | −39.7% | |
| Q1 FY26 | −40.1% | +13.7 pts | −41.4% | |
| Q4 FY25 | −42.4% | +16.7 pts | −44.5% | |
| Q3 FY25 | −44.2% | +29.8 pts | −49.0% | |
| Q2 FY25 | −49.9% | +26.3 pts | −55.6% | |
| Q1 FY25 | −53.8% | +22.5 pts | −58.8% | |
| Q4 FY24 | −59.0% | +26.0 pts | −60.0% | |
| Q3 FY24 | −74.0% | +6.7 pts | −74.4% | |
| Q2 FY24 | −76.2% | +23.4 pts | −79.4% | |
| Q1 FY24 | −76.3% | n/a | −87.8% | |
| Q4 FY23 | −85.0% | n/a | n/a | |
| Q3 FY23 | −80.7% | n/a | −95.8% |
Against its peers
Companies in Medical - Diagnostics & Research nearest Guardant Health's size, closest first, today.
| Company | Profit margin |
|---|---|
| GHGuardant Health | −38.3% |
| LHLabcorp | 7.0% |
| DGXQuest Diagnostics | 9.2% |
| MEDPMedpace | 17.7% |
| RVTYRevvity | 8.2% |
| MTDMettler-Toledo International | 21.9% |
| ILMNIllumina | 18.4% |
| IDXXIDEXX Laboratories | 25.0% |
| WATWaters | 3.6% |
| IQVIQVIA | 8.1% |
| AAgilent Technologies | 19.5% |
| Peer median | 13.4% |
Where Guardant Health ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Guardant Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.